FedCircuitBlog

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

• an article about how the “Federal Circuit refused . . . to rehear a challenge to a Delaware judge’s probe into the financing of patent litigation”;
• another article about “Sanofi and Regeneron on Friday urg[ing] the U.S. Supreme Court to reject Amgen’s arguments that it deserves broad patent coverage on cholesterol drugs”; and
• a blog post examining the reasons why the “Federal Circuit has ordered [Google’s] case moved out of the Western District of Texas (Waco) to the Northern District of California.”

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

• an article about a Federal Circuit decision finding “[a] Texas federal court ‘clearly abused its discretion’ when declining to transfer a patent-infringement lawsuit against Google LLC”;
• another article about the Federal Circuit “vacat[ing] what it called an ‘extraordinarily high’ legal-fee award of $185 million”; and
• a third article about how a “Virginia federal judge issued a bench trial ruling Monday that ImmunoGen is not entitled to a patent on a cancer treatment . . . after the Federal Circuit vacated the court’s previous decision and ordered a trial.”